These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37243682)

  • 21. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.
    Aicardi J; Mumford JP; Dumas C; Wood S
    Epilepsia; 1996 Jul; 37(7):638-42. PubMed ID: 8681895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing epilepsy in tuberous sclerosis complex.
    Thiele EA
    J Child Neurol; 2004 Sep; 19(9):680-6. PubMed ID: 15563014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis.
    Biswas A; Yossofzai O; Vincent A; Go C; Widjaja E
    Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN; Penney S; Buckley DJ
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
    Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
    Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brazilian experts' consensus on the treatment of infantile epileptic spasm syndrome in infants.
    Sampaio LPB; Henriques-Souza AMM; Silveira MRMD; Seguti L; Santos MLSF; Montenegro MA; Antoniuk S; Manreza MLG
    Arq Neuropsiquiatr; 2023 Sep; 81(9):844-856. PubMed ID: 37793406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current role of vigabatrin in infantile spasms.
    Parisi P; Bombardieri R; Curatolo P
    Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.
    van der Poest Clement E; Jansen FE; Braun KPJ; Peters JM
    Paediatr Drugs; 2020 Feb; 22(1):73-84. PubMed ID: 31912454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS
    Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.
    Nabbout R; Kuchenbuch M; Chiron C; Curatolo P
    CNS Drugs; 2021 Sep; 35(9):965-983. PubMed ID: 34417984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.
    Nabbout R; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; O'Callaghan F; Qin J; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC; Kingswood JC
    Front Neurol; 2021; 12():697467. PubMed ID: 34566842
    [No Abstract]   [Full Text] [Related]  

  • 36. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
    Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
    Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
    Rotta NT; da Silva AR; Ohlweiler L; Riesgo R
    Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of infantile spasms.
    Hancock E; Osborne JP; Milner P
    Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.